Equillium, Inc. (EQ) stock
EQNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.10−0.11 (-9.09%)
Close on Nov 18, 2026Market cap $69.75MP/E –Yield –
Equillium free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Equillium's free cash flow for the twelve months ending Jun 30, 2026 was -$20.09M. For fiscal 2025 it was -$22.79M. The highest annual figure on record is -$7.56M in fiscal 2018.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$22.79M | – |
| FY2024 | Dec 31, 2024 | -$19.11M | – |
| FY2023 | Dec 31, 2023 | -$21.83M | – |
| FY2022 | Dec 31, 2022 | -$9.01M | – |
| FY2021 | Dec 31, 2021 | -$32.14M | – |
| FY2020 | Dec 31, 2020 | -$24.83M | – |
| FY2019 | Dec 31, 2019 | -$23.02M | – |
| FY2018 | Dec 31, 2018 | -$7.56M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$4.18M | – |
| Q1 FY2026 | Mar 31, 2026 | -$4.30M | – |
| Q4 FY2025 | Dec 31, 2025 | -$3.18M | – |
| Q3 FY2025 | Sep 30, 2025 | -$8.43M | – |
| Q2 FY2025 | Jun 30, 2025 | -$3.01M | -551.0% |
| Q1 FY2025 | Mar 31, 2025 | -$8.17M | – |
| Q4 FY2024 | Dec 31, 2024 | -$3.30M | – |
| Q3 FY2024 | Sep 30, 2024 | -$7.66M | -127.6% |
| Q2 FY2024 | Jun 30, 2024 | $668.00K | – |
| Q1 FY2024 | Mar 31, 2024 | -$8.82M | – |
| Q4 FY2023 | Dec 31, 2023 | -$5.70M | – |
| Q4 FY2022 | Dec 31, 2022 | $27.72M | – |
| Q3 FY2022 | Sep 30, 2022 | -$13.07M | – |
| Q2 FY2022 | Jun 30, 2022 | -$11.31M | – |
| Q1 FY2022 | Mar 31, 2022 | -$12.36M | – |
| Q4 FY2021 | Dec 31, 2021 | -$10.13M | – |
| Q3 FY2021 | Sep 30, 2021 | -$7.04M | – |
| Q4 FY2020 | Dec 31, 2020 | -$8.28M | – |
| Q3 FY2020 | Sep 30, 2020 | -$5.08M | – |
| Q2 FY2020 | Jun 30, 2020 | -$5.08M | – |
| Q1 FY2020 | Mar 31, 2020 | -$6.39M | – |
| Q4 FY2019 | Dec 31, 2019 | -$9.05M | – |
| Q3 FY2019 | Sep 30, 2019 | -$4.70M | – |
| Q2 FY2019 | Jun 30, 2019 | -$4.80M | – |
| Q1 FY2019 | Mar 31, 2019 | -$4.48M | – |
| Q4 FY2018 | Dec 31, 2018 | -$3.84M | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.65M | – |
| Q2 FY2018 | Jun 30, 2018 | -$1.19M | – |
| Q1 FY2018 | Mar 31, 2018 | -$894.00K | – |
See a number that looks wrong?